Rab 13 inhibitors belong to a class of chemical compounds that have garnered attention in the fields of molecular biology and modulate specific cellular processes. Rab 13 is a member of the Rab GTPase family, which plays a critical role in regulating intracellular vesicular trafficking and protein transport. These small GTPases act as molecular switches, cycling between an active GTP-bound state and an inactive GDP-bound state, and their precise control is essential for various cellular functions. Rab 13 is primarily associated with the regulation of membrane trafficking in the endomembrane system, including processes such as vesicle formation, cargo sorting, and vesicle fusion. Rab 13 inhibitors are designed to interact with the active site or binding domain of the Rab 13 protein, effectively inhibiting its function and influencing cellular processes dependent on Rab 13-mediated vesicular transport.
Structurally, Rab 13 inhibitors are engineered to selectively target the active site or binding domains of Rab 13, ensuring high specificity for this particular Rab GTPase. By inhibiting Rab 13, these compounds may disrupt its role in vesicular trafficking and protein transport, leading to alterations in intracellular membrane dynamics and cargo delivery. The study of Rab 13 inhibitors is of significant interest to researchers as it provides insights into the regulatory mechanisms governing essential cellular functions related to membrane trafficking, organelle biogenesis, and protein secretion. This knowledge contributes to our understanding of basic cell biology and may have implications in various research areas, including cell physiology, membrane biology, and the molecular basis of diseases associated with dysregulated vesicular transport processes. However, further research is required to fully explore the extent of their applications and their impact on cellular physiology in the context of Rab 13-mediated vesicular trafficking.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose acts as a glycolysis inhibitor by interfering with glucose metabolism, which could disrupt energy production and indirectly lead to the downregulation of multiple proteins, including Rab13. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation, which is vital for the proper folding and function of many proteins. This stress could trigger a cellular response that downregulates protein expression, including Rab13. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that can cause the accumulation of misfolded proteins, potentially leading to a general downregulation of protein synthesis, affecting Rab13 levels as well. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin disrupts Golgi function by altering pH levels, which can affect vesicle formation and trafficking, possibly leading to reduced expression of trafficking-related proteins like Rab13. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin causes premature chain termination during protein synthesis, leading to a reduction in the overall levels of protein, which could include Rab13. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
Cyclopiazonic acid inhibits the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA), disrupting calcium homeostasis, which may indirectly downregulate protein synthesis including that of Rab13. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic acid can induce stress responses in cells, which may lead to a general downregulation of protein synthesis, potentially reducing the levels of proteins such as Rab13. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Homoharringtonine inhibits protein synthesis at the initial elongation step, which may result in a decrease in overall protein levels, including Rab13. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin binds to heat shock protein 90 (Hsp90) and inhibits its function, which could lead to the destabilization of many client proteins and potentially reduce the expression of proteins like Rab13. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Emetine inhibits eukaryotic protein synthesis by blocking peptide elongation, which could lead to a decrease in expression of various proteins, including Rab13. | ||||||